A breakthrough in wombanalytic detection is set to revolutionize the screening process for a life-changing disease after NHS hospitals began using an artificial intelligence (AI) blood test. The test, which uses machine learning algorithms to analyze patient blood samples, can detect cancer-causing proteins at low levels, potentially reducing the need for invasive womb cancer checks.
According to the National Health Service (NHS), around 90,000 postmenopausal women in England are referred by GPs each year after experiencing heavy bleeding, a symptom that may be indicative of womb cancer. About 10,000 women are diagnosed with the disease annually, and the NHS aims to improve the detection process through AI-powered blood tests.
The use of AI blood tests has the potential to reduce unnecessary invasive checks, which can carry risks and complications for patients. By analyzing blood samples more accurately than traditional methods, the test could help doctors identify cancer at an early stage, when it is more treatable. The NHS hospitals preparing to use this technology are likely to implement it in conjunction with other screening programs, aiming to improve the detection rate and overall care for women diagnosed with womb cancer.